Recent mumps outbreaks in the US have primarily occurred in highly vaccinated populations in close-contact settings, with most cases occurring among vaccinated young adults, a recent study found. Researchers assessed the epidemiological characteristics of mumps outbreaks with ≥20 cases reported in the US from July 2010 through December 2015. They found:
- 23 outbreaks with 20-485 cases/outbreak were reported in 18 jurisdictions.
- Median duration of outbreaks was 3 months.
- All outbreaks involved close-contact settings (78% universities, 70% occurred primarily among young adults, 39% occurred in highly vaccinated populations [2-dose measles-mumps-rubella vaccine coverage >85%]).
- Most cases occurred among vaccinated young adults (median age 18-24 years), suggesting waning immunity played a role.
Clemmons N, Redd SB, Gastanaduy PA, Marin M, Patel M, Fiebelkorn AP. Characteristics of large mumps outbreaks in the United States during July 2010–December 2015. [Published online ahead of print September 10, 2018]. Clin Infect Dis. doi:10.1093/cid/ciy779.
Over the past few years there have been more mumps outbreaks in the United States as highlighted by this article. This article raises the question of declining mumps immunity with time. This year in January, the ACIP stated that during an outbreak a patient at risk for mumps may get a 3rd dose of an MMR. Because most patients received their 2 doses of MMR prior to entry of school, it also may be possible at some time in the future that we may be administering a 3rd dose of the MMR to all patients in late adolescence. We will have to wait and see how these episodic epidemics play themselves out to make this decision. It also underscores the importance of having a high vaccination rate in the entire population to help decrease epidemics that would impact vaccinated patients with weaning immunity. —John Russell, MD
This Week's Must Reads
Dental device borrowed from sports world no help in pushing, Bergh E et al. Am J Obstet Gynecol. 2019 Jan;220(1):S39, Abstract 49
Enterovirus in at-risk children associated with later celiac disease, Kahrs CR et al. BMJ. 2019 Feb 13. doi: 10.1136/bmj.l231
List of medications linked to drug-induced lupus expands, Arnaud L et al. Ann Rheum Dis. 2019 Feb 4. doi: 10.1136/annrheumdis-2018-214598
Possible mechanism for fluoroquinolone-induced aortopathy uncovered, Guzzardi DG et al. J Thorac Cardiovasc Surg. 2019;157:109-19.
One postdelivery antibiotic dose nearly halves infection in operative delivery, Knight M. et al. Am J Obstet Gynecol 2019 Jan;220;1:S685. Abstract LB 3.
Must Reads in Vaccines
Influenza Vaccination Safety During Hospitalization, Mayo Clin Proc; ePub 2019 Jan 8; Tartof, et al
Acellular Pertussis Vaccine Is Safe & Effective, JAMA Pediatr; 2018 Nov; Wood, Nolan, et al
Influenza and Pertussis Vaccination in Pregnancy, Vaccine; ePub 2018 Nov 3; Wilcox, Bottrell, et al
Influenza Vaccine Efficacy in High-Risk Patients, Vaccine; ePub 2018 Nov 9; Shang, Chung, et al
Childhood Vaccination Coverage Rates Compared, J Paediatr Child Health; ePub 2018 Nov 13; Baumann, et al